(0.18%) 5 317.95 points
(0.23%) 39 999 points
(0.14%) 16 766 points
(0.70%) $79.18
(3.02%) $2.49
(-0.43%) $2 384.70
(0.61%) $29.91
(0.12%) $1 071.40
(0.11%) $0.920
(0.23%) $10.69
(0.06%) $0.789
(0.16%) $90.83
Live Chart Being Loaded With Signals
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa...
Stats | |
---|---|
Today's Volume | 123 527 |
Average Volume | 195 682 |
Market Cap | 51.13M |
EPS | €0 ( 2024-04-24 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -1.720 |
ATR14 | €0.00200 (0.28%) |
Volume Correlation
Novacyt SA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Novacyt SA Correlation - Currency/Commodity
Novacyt SA Financials
Annual | 2022 |
Revenue: | €21.04M |
Gross Profit: | €5.75M (27.31 %) |
EPS: | €-0.310 |
FY | 2022 |
Revenue: | €21.04M |
Gross Profit: | €5.75M (27.31 %) |
EPS: | €-0.310 |
FY | 2021 |
Revenue: | €95.78M |
Gross Profit: | €29.68M (30.99 %) |
EPS: | €-0.122 |
FY | 2020 |
Revenue: | €277.20M |
Gross Profit: | €211.13M (76.16 %) |
EPS: | €1.940 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Novacyt SA
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators